CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors
Journal of Nuclear Medicine · 2023
DOI: 10.2967/jnumed.123.265464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Ingo Hartlapp und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Desmoplastic Small Round Cell Tumor, Coordination Complexes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Desmoplastic small round cell tumor (DSRCT) is a rare, radiosensitive, yet difficult-to-treat sarcoma subtype affecting predominantly male adolescents. Extensive intraperitoneal seeding is common and requires multimodal management. With no standard therapy established, the prognosis remains poor, and new treatment options are needed. We demonstrate the clinical potential of C-X-C motif chemokine receptor 4 (CXCR4)-directed imaging and endoradiotherapy in DSRCT.
Methods
Eight male patients underwent dual-tracer imaging with [18F]FDG and CXCR4-directed [68Ga]pentixafor PET/CT. A visual comparison of both tracers, along with uptake quantification in active DSRCT lesions, was performed. [68Ga]pentixafor uptake was correlated with immunohistochemical CXCR4 expression on tumor cells. Four patients with end-stage progressive disease underwent CXCR4-based endoradiotherapy. We report the safety, response by RECIST 1.1, and survival after endoradiotherapy.
Results
Uptake of [68Ga]pentixafor in tumor lesions was demonstrated in all patients with DSRCT, providing diagnostic power comparable to [18F]FDG PET. Corresponding CXCR4 expression was confirmed by immunohistochemistry in all DSRCT biopsies. Finally, 4 patients were treated with CXCR4-directed [90Y]endoradiotherapy, 3 in a myeloablative dose range with subsequent autologous stem cell transplantation. All 3 required transfusions, and febrile neutropenia occurred in 2 patients (resulting in 1 death). Notably, severe nonhematologic adverse events were absent. We observed signs of response in all 3 patients, translating into disease stabilization in 2 patients for 143 and 176 d, respectively. In the third patient, postmortem autopsy confirmed a partial pathologic response.
Conclusion
We validated CXCR4 as a diagnostic biomarker and a promising target for endoradiotherapy in DSRCT, demonstrated its feasibility, and provided the first evidence of its clinical efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
- Department of Nuclear Medicine and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
- Department of Pathology and Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
- Department of Diagnostic and Interventional Radiology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
- Department of General, Visceral, Transplantation, Vascular, and Pediatric Surgery and Comprehensive Cancer Center Mainfranken Würzburg, University Hospital Würzburg, Würzburg, Germany.
- Children's Hospital and Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
Zitieren
APA
Hartlapp, I., Hartrampf, P. E., Serfling, S. E., Wild, V., Weich, A., Rasche, L., Roth, S., Rosenwald, A., Mihatsch, P. W., Hendricks, A., Wiegering, A., Wiegering, V., Hänscheid, H., Schirbel, A., Werner, R. A., Buck, A. K., Wester, H. J., Einsele, H., Kunzmann, V., …, & Kortüm, K. M. (2023). CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.265464
Vancouver
Hartlapp I, Hartrampf PE, Serfling SE, Wild V, Weich A, Rasche L, et al. CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.123.265464
BibTeX
@article{Hartlapp2023,
author = {Hartlapp, Ingo and Hartrampf, Philipp E and Serfling, Sebastian E and Wild, Vanessa and Weich, Alexander and Rasche, Leo and Roth, Sabine and Rosenwald, Andreas and Mihatsch, Patrick W and Hendricks, Anne and Wiegering, Armin and Wiegering, Verena and Hänscheid, Heribert and Schirbel, Andreas and Werner, Rudolf A and Buck, Andreas K and Wester, Hans-Jürgen and Einsele, Hermann and Kunzmann, Volker and Lapa, Constantin and Kortüm, K Martin},
title = {CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors},
journal = {Journal of Nuclear Medicine},
year = {2023},
doi = {10.2967/jnumed.123.265464}
}
EUVIMED